Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析

◆英語タイトル:Dicerna Pharmaceuticals Inc (DRNA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH93530FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platform GalXCTM is an advanced next-generation RNAi-based therapies that is designed to silence disease-driving genes in the liver. Dicerna’s GalXC-based therapies are processed by the Dicer enzyme, which is the natural initiation point for RNAi within the human cell. The company also develops therapies to treat diseases linking the liver such as rare, viral infections, chronic liver, and cardiovascular diseases. Dicerna is headquartered in Cambridge, Massachusetts, the US.

Dicerna Pharmaceuticals Inc Key Recent Developments

Apr 01,2021: Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 30,2021: Dicerna’s GalXC-Plus RNAi Technology delivers target knockdown across CNS and to specific CNS cell types in preclinical studies
Mar 24,2021: Dicerna to present new GalXC-Plus nonclinical CNS data at Oligonucleotide and Precision Therapeutics Virtual Congress
Mar 05,2021: Dicerna and Roche commence Hepatitis B virus therapeutic trial

This comprehensive SWOT profile of Dicerna Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dicerna Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dicerna Pharmaceuticals Inc – Key Information
Dicerna Pharmaceuticals Inc – Overview
Dicerna Pharmaceuticals Inc – Key Employees
Dicerna Pharmaceuticals Inc – Key Employee Biographies
Dicerna Pharmaceuticals Inc – Key Operational Heads
Dicerna Pharmaceuticals Inc – Major Products and Services
Dicerna Pharmaceuticals Inc – History
Dicerna Pharmaceuticals Inc – Company Statement
Dicerna Pharmaceuticals Inc – Locations And Subsidiaries
Dicerna Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dicerna Pharmaceuticals Inc – Business Description
Dicerna Pharmaceuticals Inc – Corporate Strategy
Dicerna Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Dicerna Pharmaceuticals Inc – Strengths
Dicerna Pharmaceuticals Inc – Weaknesses
Dicerna Pharmaceuticals Inc – Opportunities
Dicerna Pharmaceuticals Inc – Threats
Dicerna Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Dicerna Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dicerna Pharmaceuticals Inc, Key Information
Dicerna Pharmaceuticals Inc, Key Ratios
Dicerna Pharmaceuticals Inc, Share Data
Dicerna Pharmaceuticals Inc, Major Products and Services
Dicerna Pharmaceuticals Inc, History
Dicerna Pharmaceuticals Inc, Key Employees
Dicerna Pharmaceuticals Inc, Key Employee Biographies
Dicerna Pharmaceuticals Inc, Key Operational Heads
Dicerna Pharmaceuticals Inc, Other Locations
Dicerna Pharmaceuticals Inc, Subsidiaries
Dicerna Pharmaceuticals Inc, Key Competitors
Dicerna Pharmaceuticals Inc, SWOT Analysis
Dicerna Pharmaceuticals Inc, Ratios based on current share price
Dicerna Pharmaceuticals Inc, Annual Ratios
Dicerna Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arabian Drilling Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Arabian Drilling Company (ADC) is an oil and gas company that operates land rigs and offshore jack-up rigs. The company provides land and offshore drilling activities. It offers services such as providing drilling units on land and offshore, providing drilling services to find oil and gas ef …
  • Genworth Financial, Inc.:戦略・SWOT・企業財務分析
    Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chesapeake Utilities Corp (CPK):企業の財務・戦略的SWOT分析
    Summary Chesapeake Utilities Corp (Chesapeake), a subsidiary of Chesapeake Energy Corp is a utility service provider that markets and distributes natural gas. The utility transmits, distributes, and markets propane, electricity, and natural gas. It also provides online bill payment, energy conservat …
  • Actelion Ltd:戦略・SWOT・企業財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Rath AG:企業の戦略・SWOT・財務情報
    Rath AG - Strategy, SWOT and Corporate Finance Report Summary Rath AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dana-Farber Cancer Institute Inc:企業のM&A・事業提携・投資動向
    Dana-Farber Cancer Institute Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dana-Farber Cancer Institute Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • International Dairy Queen, Inc.:企業の戦略的SWOT分析
    International Dairy Queen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • BlackBerry Ltd:戦略・SWOT・企業財務分析
    BlackBerry Ltd - Strategy, SWOT and Corporate Finance Report Summary BlackBerry Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Imuraya Group Co., Ltd.:企業の戦略・SWOT・財務分析
    Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Uponor Oyj:企業の戦略・SWOT・財務情報
    Uponor Oyj - Strategy, SWOT and Corporate Finance Report Summary Uponor Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aster DM Healthcare (ASTERDM):製薬・医療:M&Aディール及び事業提携情報
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as mobile medical units, cardiac surgery, early cancer detection centers, village adoption, and dialys …
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆